Eric Venker Insider Trading Activity
Every SEC Form 4 transaction reported by Eric Venker, sourced directly from SEC EDGAR and updated as new filings are accepted.
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Eric Venker buying or selling?
Eric Venker reported 0 open-market buys ($0) and 58 sells ($201.9M) across 58 Form 4 filings at 2 companies — a net selling position of $201.9M.
Source: SEC EDGAR Form 4
What stands out
- Eric Venker has reported Form 4 transactions at 2 companies; the most active, Roivant Sciences Ltd. (ROIV), accounts for 55 of 58 filings (95%).
- The most recent Form 4 was accepted on Oct 5, 2026 (13 days ago).
- In the last 12 months: no open-market purchases and 14 sales ($66.3M).
- The largest open-market sale in the last 12 months was $7.3M of Roivant Sciences Ltd. (ROIV) on Oct 2, 2026. SEC ↗
Key Statistics (as of Oct 5, 2026)
Insider sentiment
Net sellingNet insider flow of $201.9M in net selling, filed between Mar 29, 2022 – Oct 5, 2026.
Companies Eric Venker files for
Recent Eric Venker transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | IMVT | Chief Executive Officer | Sale | 3.5K | $119.6K | SEC ↗ |
| Oct 2, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $7.3M | SEC ↗ |
| Sep 2, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $7.2M | SEC ↗ |
| Jul 30, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $7.0M | SEC ↗ |
| Jul 6, 2026 | IMVT | Chief Executive Officer | Sale | 3.1K | $119.0K | SEC ↗ |
| Jun 26, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $6.6M | SEC ↗ |
| May 22, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $6.1M | SEC ↗ |
| Apr 22, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $5.9M | SEC ↗ |
| Apr 3, 2026 | IMVT | Chief Executive Officer | Sale | 14.2K | $342.9K | SEC ↗ |
| Mar 19, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $5.6M | SEC ↗ |
| Feb 18, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $5.3M | SEC ↗ |
| Jan 15, 2026 | ROIV | President & Immunovant CEO | Sale | 200.0K | $4.4M | SEC ↗ |
| Dec 30, 2025 | ROIV | President & Immunovant CEO | Sale | 275.0K | $6.2M | SEC ↗ |
| Dec 12, 2025 | ROIV | President & Immunovant CEO | Sale | 200.0K | $4.2M | SEC ↗ |
| Oct 18, 2025 | ROIV | President & Immunovant CEO | Sale | 851.4K | $14.5M | SEC ↗ |
| Oct 15, 2025 | ROIV | President & Immunovant CEO | Sale | 125.7K | $2.0M | SEC ↗ |
| Oct 9, 2025 | ROIV | President & Immunovant CEO | Sale | 665.2K | $10.8M | SEC ↗ |
| Sep 24, 2025 | ROIV | President & Immunovant CEO | Sale | 1.7M | $25.5M | SEC ↗ |
| Aug 23, 2025 | ROIV | President & Immunovant CEO | Sale | 100.0K | $1.2M | SEC ↗ |
| Jul 24, 2025 | ROIV | President & Immunovant CEO | Sale | 100.0K | $1.2M | SEC ↗ |
| Jun 25, 2025 | ROIV | President & COO | Sale | 100.0K | $1.1M | SEC ↗ |
| Jun 5, 2025 | ROIV | President & COO | Sale | 1.0M | $11.2M | SEC ↗ |
| May 23, 2025 | ROIV | President & COO | Sale | 100.0K | $1.1M | SEC ↗ |
| Apr 23, 2025 | ROIV | President & COO | Sale | 100.0K | $1.0M | SEC ↗ |
| Mar 25, 2025 | ROIV | President & COO | Sale | 750.0K | $8.2M | SEC ↗ |
Showing the 25 most recent filings of 58. Screen every filing.
Eric Venker insider trading FAQ
Is Eric Venker buying or selling?
Across 58 SEC Form 4 filings, Eric Venker reported 0 open-market purchases totaling $0 and 58 sales totaling $201.9M — a net selling position of $201.9M.
Which companies does Eric Venker file Form 4s for?
Eric Venker has reported insider transactions at 2 companies, most often Roivant Sciences Ltd. (ROIV), Immunovant, Inc. (IMVT).
How far back does Eric Venker's filing history go?
Trabud holds Eric Venker's SEC Form 4 filings from Mar 29, 2022 – Oct 5, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Eric Venker's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Eric Venker and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener